McKesson recalls

All McKesson recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (3).

3 recalls published between February 5, 2025 and July 8, 2026. Most common issues: manufacturing practices (cgmp) (1). 1 was FDA Class I, the most serious level.

• Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL)… recall
  FDA July 8, 2026 · McKesson · Class II
• UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled… recall
  FDA February 18, 2026 · McKesson · Class I
• Inflectra (infliximab-dyyb), For injection, 100mg per vial… recall
  FDA February 5, 2025 · McKesson · Class II